IntelliPharmaCeutics International (TSXV:IPCI) Dividends per Share : C$0.00 (TTM As of Aug. 2023)

View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International Dividends per Share?

IntelliPharmaCeutics International's dividends per share for the three months ended in Aug. 2023 was C$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Aug. 2023 was C$0.00. Its Dividend Payout Ratio for the three months ended in Aug. 2023 was 0.00. As of today, IntelliPharmaCeutics International's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

IntelliPharmaCeutics International Dividends per Share Historical Data

The historical data trend for IntelliPharmaCeutics International's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Dividends per Share Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Dividends per Share

Get a 7-Day Free Trial

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of IntelliPharmaCeutics International's Dividends per Share

For the Biotechnology subindustry, IntelliPharmaCeutics International's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Dividend Yield % falls into.

IntelliPharmaCeutics International Dividends per Share Calculation

Dividends paid to per common share.

IntelliPharmaCeutics International (TSXV:IPCI) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

IntelliPharmaCeutics International's Dividend Payout Ratio for the quarter that ended in Aug. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Aug. 2023 )	/	EPS without NRI (Q: Aug. 2023 )
	=	0	/	-0.079
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

IntelliPharmaCeutics International Dividends per Share Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

IPCIF:USA I4AA:Germany

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines